Assessing vitamin D in the central nervous system

被引:19
作者
Holmoy, T. [1 ,2 ]
Moen, S. M. [1 ,2 ]
机构
[1] Oslo Univ Hosp Ulleval, Dept Neurol, Oslo, Norway
[2] Univ Oslo, Fac Med, Oslo, Norway
来源
ACTA NEUROLOGICA SCANDINAVICA | 2010年 / 122卷
关键词
cerebrospinal fluid; multiple sclerosis; vitamin D; MULTIPLE-SCLEROSIS; D-RECEPTOR; 1,25-DIHYDROXYVITAMIN D-3; BRAIN; 25-HYDROXYVITAMIN-D; IDENTIFICATION; DEFICIENCY; TRANSPORT; PROTECTS; INDUCER;
D O I
10.1111/j.1600-0404.2010.01383.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Epidemiological and experimental evidence suggest that vitamin D deficiency is a risk factor for multiple sclerosis and other autoimmune diseases. The activated form of vitamin D exerts several immunomodulating properties in vitro and in vivo, that could contribute to explain the association with multiple sclerosis. Hypovitaminosis D is also associated with several other neurological diseases that is less likely mediated by dysregulated immune responses, including Parkinson's disease and Alzheimer's disease, schizophrenia and affective disorders, suggesting a more diverse role for vitamin D in the maintenance of brain health. Accordingly, both the vitamin D receptor and the enzymes necessary to synthesize bioactive 1,25-dihydroxyvitamin D are expressed in the brain, and hypovitaminosis D is associated with abnormal development and function of the brain. We here review current knowledge on the intrathecal vitamin D homeostasis in heath and disease, highlighting the need to assess vitamin D in the intrathecal compartment.
引用
收藏
页码:88 / 92
页数:5
相关论文
共 46 条
[1]  
Baas D, 2000, GLIA, V31, P59, DOI 10.1002/(SICI)1098-1136(200007)31:1<59::AID-GLIA60>3.0.CO
[2]  
2-Y
[3]   25-HYDROXYVITAMIN-D, 24, 25-DIHYDROXYVITAMIN-D AND 1,25-DIHYDROXYVITAMIN-D IN HUMAN CEREBROSPINAL-FLUID [J].
BALABANOVA, S ;
RICHTER, HP ;
ANTONIADIS, G ;
HOMOKI, J ;
KREMMER, N ;
HANLE, J ;
TELLER, WM .
KLINISCHE WOCHENSCHRIFT, 1984, 62 (22) :1086-1090
[4]   Vitamin D and Human Health: Lessons from Vitamin D Receptor Null Mice [J].
Bouillon, Roger ;
Carmeliet, Geert ;
Verlinden, Lieve ;
van Etten, Evelyne ;
Verstuyf, Annemieke ;
Luderer, Hilary F. ;
Lieben, Liesbet ;
Mathieu, Chantal ;
Demay, Marie .
ENDOCRINE REVIEWS, 2008, 29 (06) :726-776
[5]   Calcitriol protects against the dopamine- and serotonin-depleting effects of neurotoxic doses of methamphetamine [J].
Cass, Wayne A. ;
Smith, Michael P. ;
Peters, Laura E. .
CELLULAR AND MOLECULAR MECHANISMS OF DRUGS OF ABUSE AND NEUROTOXICITY: COCAINE, GHB, AND SUBSTITUTED AMPHETAMINES, 2006, 1074 :261-271
[6]   Change in sex ratio, disease course and age at diagnosis in Oslo MS patients through seven decades [J].
Celius, E. G. ;
Smestad, C. .
ACTA NEUROLOGICA SCANDINAVICA, 2009, 120 :27-29
[7]   Immunomodulatory effects of Vitamin D in multiple sclerosis [J].
Correale, Jorge ;
Celica Ysrraelit, Mara ;
Ines Gaitan, Maria .
BRAIN, 2009, 132 :1146-1160
[8]  
DEAPREU DA, 2009, PSYCHONEUROENDOCR S1, V34, P265
[9]   Distribution of the Vitamin D receptor and 1α-hydroxylase in human brain [J].
Eyles, DW ;
Smith, S ;
Kinobe, R ;
Hewison, M ;
McGrath, JJ .
JOURNAL OF CHEMICAL NEUROANATOMY, 2005, 29 (01) :21-30
[10]  
Eyles DW., 2009, Psychoneuroendocnnology, V34, pS247, DOI [10.1016/j.psyneuen.2009.04.015, DOI 10.1016/J.PSYNEUEN.2009.04.015]